当前位置: X-MOL 学术Clin. Transl. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pervasive inflammatory activation in patients with deficiency in very-long-chain acyl-coA dehydrogenase (VLCADD)
Clinical & Translational Immunology ( IF 5.8 ) Pub Date : 2021-06-27 , DOI: 10.1002/cti2.1304
Abbe N Vallejo 1, 2, 3 , Henry J Mroczkowski 3, 4, 5 , Joshua J Michel 1 , Michael Woolford 1 , Harry C Blair 6, 7, 8 , Patricia Griffin 1 , Elizabeth McCracken 3, 4, 9 , Stephanie J Mihalik 4, 6 , Miguel Reyes-Mugica 3, 6 , Jerry Vockley 3, 4, 9, 10
Affiliation  

Very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD) is a disorder of fatty acid oxidation. Symptoms are managed by dietary supplementation with medium-chain fatty acids that bypass the metabolic block. However, patients remain vulnerable to hospitalisations because of rhabdomyolysis, suggesting pathologic processes other than energy deficit. Since rhabdomyolysis is a self-destructive process that can signal inflammatory/immune cascades, we tested the hypothesis that inflammation is a physiologic dimension of VLCADD.

中文翻译:

极长链酰基辅酶 A 脱氢酶 (VLCADD) 缺乏症患者的普遍炎症激活

超长链酰基辅酶A脱氢酶缺乏症(VLCADD)是一种脂肪酸氧化障碍。通过膳食补充绕过代谢阻滞的中链脂肪酸来控制症状。然而,由于横纹肌溶解症,患者仍然容易住院,这表明存在能量不足以外的病理过程。由于横纹肌溶解是一种可以发出炎症/免疫级联信号的自我破坏过程,我们测试了炎症是 VLCADD 的生理维度的假设。
更新日期:2021-06-28
down
wechat
bug